Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort (Q33611305)

28 July 2017

title

Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort (English)

1 reference

28 July 2017

0 references

Pierre De Beaudrap

1

0 references

Eric Delaporte

object named as

Eric Delaporte

9

0 references

Papa Salif Sow

6

object named as

Papa S Sow

1 reference

28 July 2017

Jean-François Etard

2

1 reference

28 July 2017

Assane Diouf

3

1 reference

28 July 2017

Ibrahima Ndiaye

4

1 reference

28 July 2017

Guèye Fatou N Ndèye

5

1 reference

28 July 2017

Kane Coumba T Ndèye

7

1 reference

28 July 2017

René Ecochard

8

1 reference

28 July 2017

ANRS 1215 Study Group

10

1 reference

28 July 2017

publication date

19 June 2010

1 reference

28 July 2017

published in

BMC Infectious Diseases

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

179

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

copyright license

start time

19 June 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

Random-effects models for longitudinal data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Change over time of mortality predictors after HAART initiation in a Senegalese cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Marginal analysis of recurrent events and a terminating event.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2905421

HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

Monitoring of antiretroviral therapy in low-resource settings – Authors' reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-179

AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565900

12 December 2020

Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565900

12 December 2020

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565900

12 December 2020

https://pubmed.ncbi.nlm.nih.gov/20565900

1 reference

12 December 2020

Monitoring antiretroviral failure in resource-poor settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565900

12 December 2020

HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565900

12 December 2020

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565900

12 December 2020

Identifiers

DOI

10.1186/1471-2334-10-179

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference